LONGIFENE SYRUP 200 ML

No, the Indian government has banned the use of LONGIFENE SYRUP 200 ML as an appetite stimulant [Gazette notification S.O. 6161(E)]. There are no studies available to show its rational use for increasing hunger. LONGIFENE SYRUP 200 ML is used for relieving various symptoms of allergy and motion sickness.

Yes, LONGIFENE SYRUP 200 ML can make you feel sleepy. Avoid driving, operating machinery, working at heights or participating in potentially dangerous activities till you know how this medicine affects you.

Longifene A Syrup is an oral liquid formulation containing buclizine, an antihistamine with appetite‑stimulating properties. Clinically, it is used as an adjunct in the management of underweight states or poor appetite, often in patients recovering from illness or those with reduced food intake. It is not a replacement for proper nutrition and should be used only under medical supervision.

Buclizine in Longifene A Syrup blocks histamine H1 receptors and exerts mild central sedative and anticholinergic effects, which in some individuals lead to increased appetite and higher caloric intake. Any weight gain results from eating more food and improving overall nutrition, not from the medicine directly adding body mass. Response varies, and not all patients will experience significant weight gain.

Longifene A Syrup may be prescribed for children by a pediatrician when there is a clear medical indication for appetite stimulation. However, it should never be given to a child without professional advice. Inappropriate use can cause excessive sedation, behavioral changes, or unnecessary weight gain. The doctor will decide if it is suitable and will specify the regimen and duration.

Some patients notice an increase in appetite within a few days of starting Longifene A Syrup, while others may require a longer period. Clinically meaningful weight gain, if it occurs, usually takes several weeks and depends on adequate calorie intake and management of underlying conditions. If there is no improvement after a reasonable trial period, the prescribing doctor should reassess the treatment plan.

Commonly reported side effects include drowsiness, dizziness, dry mouth, constipation, mild stomach discomfort, and sometimes blurred vision. These effects are related to the antihistaminic and anticholinergic actions of buclizine. Most are mild and transient, but if they become troublesome, persistent, or are accompanied by confusion, palpitations, or difficulty urinating, medical advice is required.

Longifene A Syrup can interact with other central nervous system depressants such as sedatives, sleeping pills, certain antidepressants, antipsychotics, and alcohol, leading to enhanced drowsiness and impaired alertness. It may also add to the anticholinergic burden when combined with similar agents, increasing the risk of dry mouth, constipation, urinary retention, or blurred vision. Patients should inform their healthcare provider about all prescription drugs, over‑the‑counter medicines, and herbal supplements before starting Longifene A Syrup.

Longifene A Syrup can cause drowsiness, dizziness, and slowed reaction time in some individuals. Until you know how you personally respond, you should avoid driving, operating machinery, or performing tasks that require full mental alertness. If you experience persistent sedation or impaired concentration, discuss this with your doctor, as dose adjustment or discontinuation may be necessary.

Elderly patients may be more sensitive to the sedative and anticholinergic effects of buclizine, such as confusion, dizziness, orthostatic hypotension, urinary retention, and constipation. Use in older adults requires particular caution, with careful assessment of risks and benefits by the prescribing physician. Close monitoring for cognitive changes, falls, and bowel or urinary problems is recommended.

Data on the safety of buclizine during pregnancy and breastfeeding are limited. Longifene A Syrup should be used in pregnant women only if the potential benefit clearly outweighs possible risks, as judged by the treating physician. During breastfeeding, there is a theoretical risk of sedation or irritability in the infant if the drug passes into breast milk. Therefore, use in lactating women should be cautious and only on medical advice, with monitoring of the infant for unusual sleepiness or feeding difficulties.

If you miss a scheduled dose, take it as soon as you remember, unless it is almost time for the next dose. In that case, skip the missed dose and resume your regular schedule. Do not double the dose to make up for the missed one, as this may increase the risk of side effects such as excessive drowsiness or dizziness. If you frequently forget doses, discuss adherence strategies with your healthcare provider.

Longifene A Syrup should generally be avoided in individuals with known hypersensitivity to buclizine or any component of the formulation. Caution or avoidance is also advised in patients with narrow‑angle glaucoma, severe urinary retention, significant prostatic enlargement, severe liver or kidney impairment, or a history of severe reactions to other antihistamines. People with epilepsy, cardiovascular disease, or those taking multiple sedating or anticholinergic medicines should be evaluated carefully before use.